| EMPLOYMENT |
|
|
| 1996-Present |
Science Consultant: Clientele: Manufacturers of Diagnostic Assay Kits: diagnostic and therapeutic device developers and manufacturers; clinical laboratories in the development of "in house" assays Current Interests: Receptor mediated assays; ultrasound and microwave radiation in the control of biochemical reactions; utilization of Buckmeisterfullerenes in clinical assays and DNA of sperm. |
|
| 1991-1996 |
Chief Executive Officer, Emerald Biomedical Sciences, Inc. The Woodlands, TX. Established a CLIA '88 approved clinical laboratory for limited analysis of blood specimens using specialized assays. Developed and implemented assays for the determination of Silicone Antibody levels (SARA™ System), myelin basic protein, and collagen I antibodies at EBSI. Advanced quality assurance protocols were established and adhered to exceeding government requirements. Received two (2) patents (US 5,385,825 - an invention that preserves protein hormone analytes in blood specimens without freezing. Two publications is world renowned peer-reviewed journals. |
|
| 1989-1991 |
Litigation - Science Consultant and Consultant to Biotechnology Firms |
|
| 1986-1989 |
Vice -President of Research and Development, Amtec Diagnostics International, Conroe, TX Conducted high complexity laboratory tests in conjunction with development of diagnostic test kits and other devices. Presented R & D goals in lay terms in revised Business Plan. Developed eighteen (18) new products for marketing and sale. Introduced modern biochemical methods to the manufacturing process for serological and diagnostic reagents. Seven (7) successful FDA product submissions. |
|
| 1983-1986 |
Director of Research and Development, Biotecx and Isotex Diagnostics, Friendswood, TX. Developed and manufactured radioimmunoassay kits for reference and clinical laboratories. Instrumental in the manufacture of several radio- pharmaceuticals. Introduced research on one agent useful in assessing cardiac damage after infarction. Extensive interaction with the FDA in device approval process. Company technical representative to laboratory technicians, nephrologists and cardiologists. |
|
| 1976-1983 |
Assistant Professor, Principal Investigator, Department of Experimental Medicine, Pharmacology and Cell Biophysics, Baylor College of Medicine, Houston, TX. Leader of an independent research laboratory supported by major Federal (NIH and EPA) grants. Published thirteen (13) in major peer-reviewed journals and presented numerous oral presentations at scientific meetings. Lectured at the International Union of Pharmacology, Paris, 1978. Conducted original research in molecular toxicology - the impact of organophosphates on skeletal muscle protein metabolism. |